Clinical Trial Update: Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer

View source ↗

Summary

This clinical trial is evaluating mismatch repair (MMR) status and PD-L1 expression in pancreatic cancer using specimens obtained by endoscopic ultrasound-guide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Ponderas Academic Hospital | Conditions: Pancreatic Cancer | Status: UNKNOWN